Skip to content
Home » Krispy Kreme’s stock gets downgraded as analyst says weight-loss drugs could hurt donut sales

Krispy Kreme’s stock gets downgraded as analyst says weight-loss drugs could hurt donut sales

    Truist said it has no idea what the impact of GLP-1 drugs will be on overall food consumption. "That, in our opinion, is the problem."

    Read full NASCAR article on Yahoo Sports

    Read all NASCAR articles